Yext (YEXT) 10-Q 9 Jun 22 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2022	May 25, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2022
Document Transition Report	false
Entity File Number	001-38056
Entity Registrant Name	YEXT, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-8059722
Entity Address, Address Line One	61 Ninth Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10011
City Area Code	212
Local Phone Number	994-3900
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	YEXT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Reporting Company	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		123,588,182
Entity Central Index Key	0001614178
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 247,769	$ 261,210
Accounts receivable, net of allowances of $1,187 and $2,042, respectively	58,012	101,607
Prepaid expenses and other current assets	19,035	13,538
Costs to obtain revenue contracts, current	32,015	33,998
Total current assets	356,831	410,353
Property and equipment, net	71,555	74,604
Operating lease right-of-use assets	93,554	97,124
Costs to obtain revenue contracts, non-current	23,852	27,286
Goodwill	4,401	4,572
Intangible assets, net	211	217
Other long term assets	5,030	6,179
Total assets	555,434	620,335
Current liabilities:
Accounts payable, accrued expenses and other current liabilities	54,449	48,432
Unearned revenue, current	196,379	223,427
Operating lease liabilities, current	18,236	18,845
Total current liabilities	269,064	290,704
Operating lease liabilities, non-current	109,959	113,776
Other long term liabilities	3,491	3,985
Total liabilities	382,514	408,465
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 50,000,000 shares authorized at April 30, 2022 and January 31, 2022; zero shares issued and outstanding at April 30, 2022 and January 31, 2022	0	0
Common stock, $0.001 par value per share; 500,000,000 shares authorized at April 30, 2022 and January 31, 2022; 139,407,429 and 137,662,320 shares issued at April 30, 2022 and January 31, 2022, respectively; 128,063,911 and 131,156,986 shares outstanding at April 30, 2022 and January 31, 2022, respectively	139	137
Additional paid-in capital	855,284	834,429
Accumulated other comprehensive loss	(3,601)	(187)
Accumulated deficit	(636,443)	(610,604)
Treasury stock, at cost	(42,459)	(11,905)
Total stockholders’ equity	172,920	211,870
Total liabilities and stockholders’ equity	$ 555,434	$ 620,335

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 1,187	$ 2,042
Preferred stock par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock shares authorized (in shares)	50,000,000	50,000,000
Preferred stock shares issued (in shares)	0	0
Preferred stock shares outstanding (in shares)	0	0
Common stock par value (in dollars per share)	$ 0.001	$ 0.001
Common stock shares authorized (in shares)	500,000,000	500,000,000
Common stock shares issued (in shares)	139,407,429	137,662,320
Common stock shares outstanding (in shares)	128,063,911	131,156,986

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Income Statement [Abstract]
Revenue	$ 98,802	$ 91,992
Cost of revenue	24,728	21,854
Gross profit	74,074	70,138
Operating expenses:
Sales and marketing	60,779	55,166
Research and development	17,302	13,857
General and administrative	21,495	18,347
Total operating expenses	99,576	87,370
Loss from operations	(25,502)	(17,232)
Interest income	25	6
Interest expense	(143)	(132)
Other expense, net	129	(86)
Loss from operations before income taxes	(25,491)	(17,444)
(Provision for) benefit from income taxes	(348)	(187)
Net loss	$ (25,839)	$ (17,631)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.20)	$ (0.14)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.20)	$ (0.14)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares)	131,144,055	125,372,839
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	131,144,055	125,372,839
Other comprehensive (loss) income:
Foreign currency translation adjustment	$ (3,414)	$ 355
Total comprehensive loss	$ (29,253)	$ (17,276)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury Stock
Beginning of period (in shares) at Jan. 31, 2021		123,989,000
Beginning of period at Jan. 31, 2021	$ 207,235	$ 130	$ 733,933	$ 2,422	$ (517,345)	$ (11,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		1,069,000
Exercise of stock options	12,111	$ 1	12,110
Vested restricted stock units converted to common shares (in shares)		871,000
Vested restricted stock units converted to common shares	0	$ 1	(1)
Issuance of restricted stock (in shares)		4,000
Issuance of restricted stock	0
Issuance of common stock under employee stock purchase plan (in shares)		282,000
Issuance of common stock under employee stock purchase plan	3,817		3,817
Stock-based compensation	15,288		15,288
Other comprehensive income (loss)	355			355
Net loss	(17,631)				(17,631)
End of period (in shares) at Apr. 30, 2021		126,215,000
End of period at Apr. 30, 2021	221,175	$ 132	765,147	2,777	(534,976)	(11,905)
Beginning of period (in shares) at Jan. 31, 2021		123,989,000
Beginning of period at Jan. 31, 2021	207,235	$ 130	733,933	2,422	(517,345)	(11,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		2,220,000
Exercise of stock options	19,197	$ 2	19,195
Vested restricted stock units converted to common shares (in shares)		4,402,000
Vested restricted stock units converted to common shares	0	$ 4	(4)
Issuance of restricted stock (in shares)		15,000
Issuance of restricted stock	0
Issuance of common stock under employee stock purchase plan (in shares)		531,000
Issuance of common stock under employee stock purchase plan	6,485	$ 1	6,484
Stock-based compensation	74,821		74,821
Other comprehensive income (loss)	(2,609)			(2,609)
Net loss	(93,259)				(93,259)
End of period (in shares) at Jan. 31, 2022		131,157,000
End of period at Jan. 31, 2022	$ 211,870	$ 137	834,429	(187)	(610,604)	(11,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	122,519	123,000
Exercise of stock options	$ 302	$ 0	302
Vested restricted stock units converted to common shares (in shares)		1,165,000
Vested restricted stock units converted to common shares	0	$ 1	(1)
Issuance of common stock under employee stock purchase plan (in shares)		457,000
Issuance of common stock under employee stock purchase plan	2,354	$ 1	2,353
Stock-based compensation	18,201		18,201
Repurchase of common stock (in shares)		(4,838,000)
Repurchase of common stock	(30,554)					(30,554)
Other comprehensive income (loss)	(3,414)			(3,414)
Net loss	(25,839)				(25,839)
End of period (in shares) at Apr. 30, 2022		128,064,000
End of period at Apr. 30, 2022	$ 172,920	$ 139	$ 855,284	$ (3,601)	$ (636,443)	$ (42,459)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Operating activities:
Net loss	$ (25,839)	$ (17,631)	$ (93,259)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	4,387	3,717
Bad debt expense	(650)	181
Stock-based compensation expense	18,086	14,598
Amortization of operating lease right-of-use assets	2,370	2,278
Other, net	302	161
Changes in operating assets and liabilities:
Accounts receivable	42,680	41,914
Prepaid expenses and other current assets	(5,685)	1,221
Costs to obtain revenue contracts	4,383	(5,534)
Other long term assets	678	(156)
Accounts payable, accrued expenses and other current liabilities	4,987	1,945
Unearned revenue	(24,519)	(5,186)
Operating lease liabilities	(3,151)	(2,786)
Other long term liabilities	(168)	341
Net cash provided by operating activities	17,861	35,063
Investing activities:
Capital expenditures	(1,644)	(7,457)
Net cash used in investing activities	(1,644)	(7,457)
Financing activities:
Proceeds from exercise of stock options	311	12,168
Repurchase of common stock	(27,142)	0
Payments of deferred financing costs	(68)	(44)
Proceeds, net from employee stock purchase plan withholdings	606	1,483
Net cash (used in) provided by financing activities	(26,293)	13,607
Effect of exchange rate changes on cash and cash equivalents	(3,365)	475
Net (decrease) increase in cash and cash equivalents	(13,441)	41,688
Cash and cash equivalents at beginning of period	261,210	230,411	230,411
Cash and cash equivalents at end of period	$ 247,769	$ 272,099	$ 261,210

Organization and Description of

Organization and Description of Business	3 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business Yext, Inc. ("Yext" or the "Company") organizes a business's facts so it can provide official answers to consumer questions starting with the business's own website and then extending across search engines and voice assistants. The Yext platform lets businesses structure the facts about their brands in a database called the Knowledge Graph. The platform is built to leverage the structured data stored in the Knowledge Graph to deliver a modern search experience on a business's or organization's own website, as well as across approximately 200 service and application providers, which the Company refers to as its Knowledge Network and includes Amazon Alexa, Apple Maps, Bing, Cortana, Facebook, Google, Google Assistant, Google Maps, Siri and Yelp. The Yext platform powers all of the Company's key features, including Listings, Pages, and Answers, along with its other features and capabilities. Fiscal Year The Company's fiscal year ends on January 31 st . References to fiscal 2023, for example, are to the fiscal year ending January 31, 2023.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on March 18, 2022 (the "Form 10-K"). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three months ended April 30, 2022 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending January 31, 2023, or any other period. There have been no material changes to the Company's significant accounting policies as described in the Form 10-K. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of those financial statements and the reported amounts of revenue and expense during the reporting period. These estimates include, but are not limited to, the standalone selling prices of performance obligations, the incremental borrowing rate associated with lease liabilities, the useful life of capitalized costs to obtain revenue contracts, income taxes, and the valuation and assumptions underlying stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the financial position and results of operations. Segment Information The Company is the provider of the Yext platform and operates as one operating segment. An operating segment is defined as a component of an enterprise for which separate financial information is evaluated regularly by the chief operating decision makers ("CODM"). The Company defines its CODM as its executive officers, and their role is to make decisions about allocating resources and assessing performance. The Company's business operates as one operating segment as all of the Company's offerings operate on the Yext platform and are deployed in an identical way, with its CODM evaluating the Company's financial information, resources and performance of these resources on a consolidated basis. Since the Company operates as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements. Concentration of Credit Risk Certain financial instruments that could be exposed to a concentration of credit risk include cash and cash equivalents and accounts receivable. The Company deposits its cash with financial institutions, and such deposits, at times, may exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Collateral is not required for accounts receivable. At April 30, 2022 and January 31, 2022, no single customer accounted for more than 10% of the Company's accounts receivable. No single customer accounted for more than 10% of the Company's revenue for the three months ended April 30, 2022 and 2021, respectively. Recent Accounting Pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The standard requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts, provided such contracts had been appropriately accounted for under ASC 606 by the acquiree, rather than recognizing them at their estimated fair value on the acquisition date as required under the existing guidance. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022 on a prospective basis, with early adoption permitted. This standard is effective for the Company in fiscal year 2024. We do not expect the adoption of this standard to have a significant impact on its consolidated financial statements.

Revenue

Revenue	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Performance Obligations The Company has identified that it has two distinct performance obligations: subscription and associated support to the Yext platform and professional services. The Company's revenue is predominantly related to its subscription and associated support to the Yext platform. Professional services revenue accounted for approximately 9% and 8% of the Company's total revenue for the three months ended April 30, 2022 and 2021, respectively. Geographic Region The Company disaggregates its revenue from contracts with customers by geographic region, as it believes this best depicts how the nature, amount, timing, and uncertainty of its revenues and cash flows are affected by economic factors. Revenue by geographic region is determined based on the region of the Company's contracting entity, which may be different than the region of its customers. The following table presents the Company's revenue by geographic region: Three months ended April 30, (in thousands) 2022 2021 North America $ 78,709 $ 73,060 International 20,093 18,932 Total revenue $ 98,802 $ 91,992 North America revenue is attributable to the United States. International revenue is predominantly attributable to European countries, but also includes Japan. The Company's revenue attributable to the United States represented 80% of total revenue, revenue attributable to England, which serves as the Company's main contracting entity for Europe, represented 18% of total revenue, and no other individual country represented more than 10% of total revenue for the three months ended April 30, 2022. The Company's revenue attributable to the United States represented 79% of total revenue, revenue attributable to England, which serves as the Company's main contracting entity for Europe, represented 18% of total revenue, and no other individual country represented more than 10% of total revenue for the three months ended April 30, 2021. Contract Liabilities A contract liability is an obligation to transfer goods or services for which consideration has been received or is due to a customer. The Company's contract liabilities consist primarily of unearned revenue and, to a lesser extent, customer deposits. As of April 30, 2022, unearned revenue, current was $196.4 million, while unearned revenue, non-current, which is included within other long term liabilities on the Company's condensed consolidated balance sheet, was $0.3 million. Revenue recognized of $86.2 million during the three months ended April 30, 2022 was included in unearned revenue at the beginning of the period. Customer deposits represent payments received in advance in instances where a revenue contract is cancelable in nature, and therefore the Company does not have an unconditional obligation to transfer control to a customer. As of April 30, 2022 and January 31, 2022, customer deposits of $1.5 million and $0.2 million were included in accounts payable, accrued expenses and other current liabilities on the Company's condensed consolidated balance sheet, respectively. Remaining Performance Obligations The transaction price allocated to remaining performance obligations represents amounts under non-cancelable contracts expected to be recognized as revenue in future periods, and may be influenced by several factors, including seasonality, the timing of renewals, and contract terms. As of April 30, 2022, the Company had $360.6 million of remaining performance obligations, of which $341.1 million is expected to be recognized as revenue over the next twenty-four months, with the remaining balance expected to be recognized thereafter. As of January 31, 2022, the Company had $404.9 million of remaining performance obligations.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings or other comprehensive (loss) income when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 inputs are based on quoted prices in active markets for identical assets or liabilities. Level 2 inputs are based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.

Goodwill

Goodwill	3 Months Ended
	Apr. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill As of April 30, 2022 and January 31, 2022, the Company had goodwill of $4.4 million and $4.6 million, respectively. The changes to goodwill during these periods related to foreign currency. Goodwill is not amortized but is subject to periodic testing for impairment at the reporting unit level, which is at or one level below the operating segment level. The Company operates as one operating segment, which represents its one reporting unit. The test for impairment is conducted annually each November 1 st , or more frequently if events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company determined that no events occurred or circumstances changed that would more likely than not reduce the fair value of the Company's reporting unit below its carrying amount during the three months ended April 30, 2022 and 2021. However, if certain events occur or circumstances change, it may be necessary to record impairment charges in the future.

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment are recorded at cost and depreciated or amortized on a straight-line basis over their estimated useful lives. Property and equipment, net consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Computer software $ 19,885 $ 18,814 Office equipment 19,507 18,854 Furniture and fixtures 7,965 8,163 Leasehold improvements 62,042 62,784 Construction in progress 1,569 936 Software in progress 706 1,342 Total property and equipment, gross 111,674 110,893 Less: accumulated depreciation (40,119) (36,289) Total property and equipment, net $ 71,555 $ 74,604 T he Company's property and equipment, net attributable to the United States was 90% as of both April 30, 2022 and January 31, 2022 . No other individual country represented more than 10% of the total property and equipment, net as of those periods. Depreciation expense was $4.4 million and $3.6 million for the three months ended April 30, 2022 and 2021, respectively.

Accounts Payable, Accrued Expen

Accounts Payable, Accrued Expenses and Other Current Liabilities	3 Months Ended
	Apr. 30, 2022
Payables and Accruals [Abstract]
Accounts Payable, Accrued Expenses and Other Current Liabilities	Accounts Payable, Accrued Expenses and Other Current Liabilities Accounts payable, accrued expenses and other current liabilities consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Accounts payable $ 11,446 $ 9,218 Accrued employee compensation 16,593 17,589 Accrued Knowledge Network application provider fees 2,909 2,885 Accrued professional services and associated costs 2,341 2,663 Accrued employee stock purchase plan withholdings liability 650 2,397 Other current liabilities 20,510 13,680 Total accounts payable, accrued expenses and other current liabilities $ 54,449 $ 48,432

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Apr. 30, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2008 Equity Incentive Plan The Company's 2008 Equity Incentive Plan (the "2008 Plan"), as amended on March 10, 2016, allowed for the issuance of up to 25,912,531 shares of common stock. Awards granted under the 2008 Plan may be incentive stock options ("ISOs"), nonqualified stock options ("NQSOs"), restricted stock and restricted stock units. The 2008 Plan is administered by the Company's Board of Directors, which determines the terms of the options granted, the exercise price, the number of shares subject to option and the option vesting period. No ISO or NQSO is exercisable after 10 years from the date of grant, and option awards will typically vest over a four-year period. The 2008 Plan was terminated in connection with the adoption of the Company's 2016 Equity Incentive Plan (the "2016 Plan") in December 2016, and since the 2008 Plan termination the Company has not granted and will not grant any additional awards under the 2008 Plan. However, the 2008 Plan will continue to govern the terms and conditions of the outstanding awards previously granted thereunder. 2016 Equity Incentive Plan In December 2016, the Company's Board of Directors adopted, and its stockholders approved, the 2016 Plan. The number of shares reserved for issuance under the 2016 Plan will increase on the first day of each fiscal year during the term of the 2016 Plan by the lesser of: (i) 10,000,000 shares, (ii) 4% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii) such other amount as the Company's Board of Directors may determine. On February 1, 2022, the number of shares of common stock available for issuance under the 2016 Plan was automatically increased according to its terms by 5,246,279 shares. In addition, the shares reserved for issuance under the 2016 Plan also include shares returned to the 2008 Plan as the result of expiration or termination of options or other awards. As of April 30, 2022, the number of shares available for future award under the 2016 Plan is 6,334,782. Stock Options The following table summarizes the activity related to the Company's stock options: Outstanding Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value Balance, January 31, 2022 6,620,701 $ 7.28 4.32 $ 11,723 Granted — $ — Exercised (122,519) $ 2.48 Forfeited or canceled (935,500) $ 12.47 Balance, April 30, 2022 5,562,682 $ 6.52 3.78 $ 2,338 Vested and expected to vest 5,562,682 $ 6.52 3.78 $ 2,338 Exercisable at April 30, 2022 5,562,682 $ 6.52 3.78 $ 2,338 The aggregate intrinsic value of options vested and expected to vest and exercisable is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of April 30, 2022. The fair value of the common stock is the Company’s closing stock price as reported on the New York Stock Exchange. The aggregate intrinsic value of exercised options was $0.5 million and $6.3 million for the three months ended April 30, 2022 and 2021, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the exercise date. Restricted Stock and Restricted Stock Units The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Outstanding Weighted-Average Grant Date Fair Value Balance as of January 31, 2022 10,184,214 $ 14.38 Granted 2,943,582 $ 7.58 Vested and converted to shares (1,174,990) $ 15.33 Forfeited or canceled (1,670,799) $ 14.51 Balance as of April 30, 2022 10,282,007 $ 11.94 The estimated weighted-average grant date fair value of restricted stock and restricted stock units granted was $7.58 and $15.42 per share for the three months ended April 30, 2022 and 2021, respectively. The fair value of the common stock is the Company’s closing stock price as reported on the New York Stock Exchange. Employee Stock Purchase Plan In March 2017, the Company's Board of Directors adopted, and its stockholders approved, the 2017 Employee Stock Purchase Plan ("ESPP"), which became effective on the date it was adopted. The number of shares of the Company's common stock that will be available for sale to employees under the ESPP increases annually on the first day of each fiscal year in an amount equal to the lesser of: (i) 2,500,000 shares; (ii) 1% of the outstanding shares of the Company's common stock as of the last day of the immediately preceding fiscal year; or (iii) such other amount as the administrator may determine. On February 1, 2022, the number of shares of common stock available for issuance under the ESPP was automatically increased according to its terms by 1,311,569 shares. As of April 30, 2022, a total of 4,397,670 shares of the Company's common stock are available for sale to employees under the ESPP. In connection with the offering period which ended on March 15, 2022, 457,595 shares of common stock were purchased under the ESPP at a purchase price of $5.14 per share for total proceeds of $2.4 million. A new offering period began on March 15, 2022 and will end on September 15, 2022. As of April 30, 2022, 340,938 shares are estimated to be purchased at the end of the offering period and $0.7 million has been withheld on behalf of employees for these future purchases under the ESPP and is included in accounts payable, accrued expenses and other current liabilities. The Black-Scholes option pricing model assumptions estimated at the commencement of the new offering period and used to calculate the fair value of shares to be purchased during an ESPP offering period included expected lives of 0.5 years, expected volatility of 48.87% and 59.24%, and risk-free rates of 0.86% and 0.06%, for the three months ended April 30, 2022 and 2021, respectively. The expected life assumptions were based on each offering period's respective purchase date. The Company estimated the expected volatility assumption based on the historical volatility of its stock price. The risk-free rate assumptions were based on the U.S. treasury yield curve in effect at commencement of the offering period. The dividend yield assumption was zero as the Company has not historically paid any dividends and does not expect to declare or pay any dividends in the foreseeable future. During the three months ended April 30, 2022 and 2021, the Company recorded stock-based compensation expense associated with the ESPP of $0.4 million and $0.6 million, respectively. As of April 30, 2022, total unrecognized compensation cost related to ESPP was $0.4 million, net of estimated forfeitures, which will be amortized over a weighted-average remaining period of 0.38 years. A new offering period commences on the first trading day on or after March 15 th and September 15 th each year, or on such other date as the administrator will determine, and will end on the first trading day, approximately six months later, on or after September 15 th and March 15 th , respectively. Participants may purchase the Company’s common stock through payroll deductions, up to a maximum of 15% of their eligible compensation. Unless changed by the administrator, the purchase price for each share of common stock purchased under the ESPP will be 85% of the lower of the fair market value per share on the first trading day of the applicable offering period or the fair market value per share on the last trading day of the applicable offering period. Performance-based Restricted Stock Units During the three months ended April 30, 2022, the Company made a grant to an executive in the form of 2,000,000 performance-based restricted stock units. This grant was outside of the Company’s 2016 Equity Incentive Plan. These performance-based restricted stock units are subject to the achievement of certain stock price targets. The Company uses a Monte Carlo simulation model to determine the fair value of this award and recognizes expense using the accelerated attribution method over the requisite service period. Stock-Based Compensation Expense Stock-based compensation represents the cost related to stock-based awards granted in lieu of monetary payment. The Company measures stock-based compensation associated with stock-based awards issued to employees at the grant date, based on the estimated fair value of the award, and recognizes expense, net of estimated forfeitures, over the vesting period of the applicable award using the straight-line method. The Company's stock-based compensation expense for the periods presented was as follows: Three months ended April 30, (in thousands) 2022 2021 Cost of revenue $ 1,382 $ 1,445 Sales and marketing 6,376 5,501 Research and development 4,520 3,988 General and administrative 5,808 3,664 Total stock-based compensation expense $ 18,086 $ 14,598 During the three months ended April 30, 2022 and 2021, the Company capitalized $0.1 million and $0.7 million, respectively of stock-based compensation related to software development.

Equity

Equity	3 Months Ended
	Apr. 30, 2022
Equity [Abstract]
Equity	Equity The following table summarizes the changes in stockholders' equity during the three months ended April 30, 2022: Accumulated Additional Other Total Common Stock Paid-In Comprehensive Accumulated Treasury Stockholders’ (in thousands) Shares Amount Capital (Loss) Deficit Stock Equity Balance, January 31, 2022 131,157 $ 137 $ 834,429 $ (187) $ (610,604) $ (11,905) $ 211,870 Exercise of stock options 123 — 302 — — — 302 Vested restricted stock units converted to common shares 1,165 1 (1) — — — — Issuance of common stock under employee stock purchase plan 457 1 2,353 — — — 2,354 Stock-based compensation — — 18,201 — — — 18,201 Repurchase of common stock (4,838) — — — — (30,554) (30,554) Other comprehensive loss — — — (3,414) — — (3,414) Net loss — — — — (25,839) — (25,839) Balance, April 30, 2022 128,064 $ 139 $ 855,284 $ (3,601) $ (636,443) $ (42,459) $ 172,920 The following table summarizes the changes in stockholders' equity during the three months ended April 30, 2021: Accumulated Additional Other Total Common Stock Paid-In Comprehensive Accumulated Treasury Stockholders’ (in thousands) Shares Amount Capital Income Deficit Stock Equity Balance, January 31, 2021 123,989 $ 130 $ 733,933 $ 2,422 $ (517,345) $ (11,905) $ 207,235 Exercise of stock options 1,069 1 12,110 — — — 12,111 Vested restricted stock units converted to common shares 871 1 (1) — — — — Issuance of restricted stock 4 — — — — — — Issuance of common stock under employee stock purchase plan 282 — 3,817 — — — 3,817 Stock-based compensation — — 15,288 — — — 15,288 Other comprehensive income — — — 355 — — 355 Net loss — — — — (17,631) — (17,631) Balance, April 30, 2021 126,215 $ 132 $ 765,147 $ 2,777 $ (534,976) $ (11,905) $ 221,175 Preferred Stock Effective April 2017, the Company’s Board of Directors is authorized to issue up to 50,000,000 shares of preferred stock, $0.001 par value, in one or more series without stockholder approval. The Company's Board of Directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The issuance of preferred stock could have the effect of restricting dividends on the Company’s common stock, diluting the voting power of its common stock, impairing the liquidation rights of its common stock, or delaying or preventing changes in control or management of the Company. As of April 30, 2022 and January 31, 2022, no shares of preferred stock were issued or outstanding. Common Stock As of April 30, 2022 and January 31, 2022, the Company had authorized 500,000,000 shares of voting $0.001 par value common stock. Each holder of the Company's common stock is entitled to one vote for each share on all matters to be voted upon by the stockholders and there are no cumulative rights. Subject to any preferential rights of any outstanding preferred stock, holders of the Company's common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by the Company's Board of Directors out of legally available funds. If there is a liquidation, dissolution or winding up of the Company, holders of the Company's common stock would be entitled to share in the Company's assets remaining after the payment of liabilities and any preferential rights of any outstanding preferred stock. Holders of the Company's common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of the Company's common stock will be fully paid and non-assessable. The rights, preferences and privileges of the holders of the Company's common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which the Company may designate and issue in the future. Treasury Stock As of April 30, 2022, the Company had 11,343,518 shares of treasury stock carried at its cost basis of $42.5 million. As of January 31, 2022, the Company had 6,505,334 shares of treasury stock carried at its cost basis of $11.9 million. Share Repurchase Program In March 2022, the Company's Board of Directors authorized a $100.0 million share repurchase program of the Company’s common stock. As of April 30, 2022, a total of 4,838,184 shares have been purchased at an average price of $6.32 per share for a total cost of $30.6 million since the commencement of the share repurchase program. As of April 30, 2022, there was approximately $69.4 million that remained available to be purchased under this share repurchase program. Subsequent to April 30, 2022, an additional approximately $24 million has been repurchased, bringing the total amount repurchased under the program to approximately $55 million, and therefore, as of June 9, 2022, approximately $45 million remains available to be purchased under the program. As part of the share repurchase program, shares may be purchased in open market transactions or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The timing, manner, price and amount of any repurchases will be determined at the Company’s discretion, and the share repurchase program may be suspended, terminated or modified at any time for any reason. The repurchase program does not obligate the Company to acquire any specific number of shares, and all open market repurchases will be made in accordance with Exchange Act Rule 10b-18, which sets certain restrictions on the method, timing, price and volume of open market stock repurchases.

Debt

Debt	3 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt On March 11, 2020, the Company entered into a credit agreement with Silicon Valley Bank (the “Credit Agreement”). No significant debt issuance costs were incurred in association with the Credit Agreement. In January 2021, the Company amended the Credit Agreement which modified the conditions pursuant to which subsidiaries are required to become guarantors. The Credit Agreement provides for a senior secured revolving loan facility of up to $50.0 million that matures three years after the effective date, with the right subject to certain conditions to add an incremental revolving loan facility of up to $50.0 million in the aggregate. The three-year revolving loan facility provides for borrowings up to the amount of the facility with sub-limits of up to (i) $30.0 million to be available for the issuance of letters of credit and (ii) $10.0 million to be available for swingline loans. Under the Credit Agreement, loans bear interest, at the Company's option, at an annual rate based on LIBOR or a base rate. Loans based on LIBOR shall bear interest at a rate between LIBOR plus 2.50% and LIBOR plus 3.00%, depending on the Company's average daily usage of the revolving loan facility. Loans based on the base rate shall bear interest at a rate between the base rate minus 0.50% and the base rate plus 0.00%, depending on the Company's average daily usage of the revolving loan facility. The obligations under the Credit Agreement are secured by a lien on substantially all of the tangible and intangible property of the Company and by a pledge of all of the equity interests of the Company's material direct and indirect domestic subsidiaries and 66% of each class of capital stock of any material first-tier foreign subsidiaries, subject to limited exceptions. The Credit Agreement contains customary affirmative and negative covenants and restrictions, as well as financial covenants that require the Company to maintain the year-over-year growth rate of its ordinary course recurring revenue for a trailing four fiscal quarter period above specified rates when certain liquidity thresholds are not met and to maintain a consolidated quick ratio of at least 1.50 to 1.00 tested on a monthly basis.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company calculates its year-to-date (provision for) benefit from income taxes by applying the estimated annual effective tax rate ("AETR") to year-to-date income or loss from operations before income taxes and adjusts for discrete tax items recorded in the period. During the three months ended April 30, 2022 and 2021, the Company recorded a (provision for) benefit from income taxes of $(0.3) million and $(0.2) million, respectively. The Company's effective tax rate generally differs from the U.S. federal statutory tax rate primarily due to a full valuation allowance related to the Company's net deferred tax assets in the U.S. and in certain foreign jurisdictions, partially offset by the foreign tax rate differential on non-U.S. income. The Company regularly evaluates the realizability of its deferred tax assets and establishes a valuation allowance on a jurisdictional basis if it is more likely than not that some or all the deferred tax assets will not be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, loss carryback and tax-planning strategies. Generally, more weight is given to objectively verifiable evidence, such as the cumulative loss in recent years, as a significant piece of negative evidence to overcome. To the extent sufficient positive evidence becomes available, a portion of the valuation allowance

Leases

Leases	3 Months Ended
	Apr. 30, 2022
Leases [Abstract]
Leases	Leases The Company's operating le ase arrangements are principally for office space. As of April 30, 2022, the Company had $18.2 million of operating lease liabilities, current, $110.0 million of operating lease liabilities, non-current, $93.6 million of operating lease right-of-use assets, and no financing leases, on its condensed consolidated balance sheet. The operating lease arrangements included in the measurement of lease liabilities do not include short-term leases, and had a weighted-average remaining lease term of 8.5 years and a weighted-average discount rate of 5.9%, as of April 30, 2022. During the three months ended April 30, 2022, the Company paid $5.1 million for amounts included in the measurement of lease liabilities and did not enter into any new lease arrangements. The Company recognized $6.6 million of lease expense for each the three months ended April 30, 2022 and 2021, which consisted of the following: Three months ended April 30, (in thousands) 2022 2021 Operating lease expense $ 4,280 $ 4,259 Short-term lease expense 206 188 Variable lease expense 2,145 2,165 Total lease expense $ 6,631 $ 6,612

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contractual Obligations The Company is obligated to make payments under certain non-cancelable contractual obligations in the normal course of business. The Company's contractual obligations primarily relate to its operating lease arrangements for office space. Its other contractual obligations include contracts with its Knowledge Network application providers, which generally have a term of one year, although some have a term of several years, and its software vendors, among others. These obligations represent minimum contractual payments, or the Company's best estimate for variable elements based on historical payments. The Company's contractual obligations have various expiry dates between fiscal years 2023 and 2035. As of April 30, 2022, the Company's contractual obligations are as follows (in thousands): Fiscal year ending January 31: Operating Leases Other 2023 (remainder of fiscal year) $ 14,248 $ 27,556 2024 18,788 17,161 2025 18,324 9,186 2026 19,177 1,834 2027 19,273 1,538 2028 and thereafter 75,160 394 Total $ 164,970 $ 57,669 Legal Proceedings The Company is and may be involved in various legal proceedings arising in the normal course of business. Although the results of litigation and claims cannot be predicted with certainty, currently, in the opinion of the Company, the likelihood of any material adverse impact on the Company's results of operations, cash flows or the Company's financial position for any such litigation or claims is deemed to be remote. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense costs, diversion of management resources and other factors. Warranties and Indemnifications The Yext platform is in some cases warranted to perform in a manner consistent with general industry standards that are reasonably applicable and materially in accordance with the Company's product specifications. The Company's arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party's intellectual property rights and/or if the Company breaches its contractual agreements with a customer or in instances of negligence, fraud or willful misconduct by the Company. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the accompanying condensed consolidated financial statements. The Company has also agreed to indemnify certain of its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person's service as a director or officer, including any action by the Company, arising out of that person's services as the Company's director or officer or that person's services provided to any other company or enterprise at the Company's request. The Company maintains director and officer insurance coverage that would generally enable the Company to recover a portion of future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders: Three months ended April 30, (in thousands, except share and per share data) 2022 2021 Numerator: Net loss attributable to common stockholders $ (25,839) $ (17,631) Denominator: Weighted-average common shares outstanding 131,144,055 125,372,839 Net loss per share attributable to common stockholders, basic and diluted $ (0.20) $ (0.14) Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Unvested restricted stock and restricted stock units are excluded from the denominator of basic net loss per share. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus common equivalent shares for the period, including any dilutive effect from such shares. Since the Company was in a net loss position for all periods presented, net loss per share attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive. Anti-dilutive common equivalent shares were as follows: As of April 30, 2022 2021 Options to purchase common stock 5,562,682 7,802,579 Restricted stock and restricted stock units 10,282,007 8,378,889 Shares estimated to be purchased under ESPP 340,938 213,434 Performance-based restricted stock units 2,000,000 — Total anti-dilutive common equivalent shares 18,185,627 16,394,902

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on March 18, 2022 (the "Form 10-K"). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three months ended April 30, 2022 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending January 31, 2023, or any other period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of those financial statements and the reported amounts of revenue and expense during the reporting period. These estimates include, but are not limited to, the standalone selling prices of performance obligations, the incremental borrowing rate associated with lease liabilities, the useful life of capitalized costs to obtain revenue contracts, income taxes, and the valuation and assumptions underlying stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the financial position and results of operations.
Segment Information	Segment Information The Company is the provider of the Yext platform and operates as one operating segment. An operating segment is defined as a component of an enterprise for which separate financial information is evaluated regularly by the chief operating decision makers ("CODM"). The Company defines its CODM as its executive officers, and their role is to make decisions about allocating resources and assessing performance. The Company's business operates as one operating segment as all of the Company's offerings operate on the Yext platform and are deployed in an identical way, with its CODM evaluating the Company's financial information, resources and performance of these resources on a consolidated basis. Since the Company operates as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements.
Concentration of Credit Risk	Concentration of Credit RiskCertain financial instruments that could be exposed to a concentration of credit risk include cash and cash equivalents and accounts receivable. The Company deposits its cash with financial institutions, and such deposits, at times, may exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Collateral is not required for accounts receivable.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The standard requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts, provided such contracts had been appropriately accounted for under ASC 606 by the acquiree, rather than recognizing them at their estimated fair value on the acquisition date as required under the existing guidance. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022 on a prospective basis, with early adoption permitted. This standard is effective for the Company in fiscal year 2024. We do not expect the adoption of this standard to have a significant impact on its consolidated financial statements.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents the Company's revenue by geographic region: Three months ended April 30, (in thousands) 2022 2021 North America $ 78,709 $ 73,060 International 20,093 18,932 Total revenue $ 98,802 $ 91,992

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property and equipment, net consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Computer software $ 19,885 $ 18,814 Office equipment 19,507 18,854 Furniture and fixtures 7,965 8,163 Leasehold improvements 62,042 62,784 Construction in progress 1,569 936 Software in progress 706 1,342 Total property and equipment, gross 111,674 110,893 Less: accumulated depreciation (40,119) (36,289) Total property and equipment, net $ 71,555 $ 74,604

Accounts Payable, Accrued Exp_2

Accounts Payable, Accrued Expenses and Other Current Liabilities (Tables)	3 Months Ended
	Apr. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable, Accrued Expenses and Other Current Liabilities	Accounts payable, accrued expenses and other current liabilities consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Accounts payable $ 11,446 $ 9,218 Accrued employee compensation 16,593 17,589 Accrued Knowledge Network application provider fees 2,909 2,885 Accrued professional services and associated costs 2,341 2,663 Accrued employee stock purchase plan withholdings liability 650 2,397 Other current liabilities 20,510 13,680 Total accounts payable, accrued expenses and other current liabilities $ 54,449 $ 48,432

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Apr. 30, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	The following table summarizes the activity related to the Company's stock options: Outstanding Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value Balance, January 31, 2022 6,620,701 $ 7.28 4.32 $ 11,723 Granted — $ — Exercised (122,519) $ 2.48 Forfeited or canceled (935,500) $ 12.47 Balance, April 30, 2022 5,562,682 $ 6.52 3.78 $ 2,338 Vested and expected to vest 5,562,682 $ 6.52 3.78 $ 2,338 Exercisable at April 30, 2022 5,562,682 $ 6.52 3.78 $ 2,338
Schedule of Nonvested RSU Activity	The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Outstanding Weighted-Average Grant Date Fair Value Balance as of January 31, 2022 10,184,214 $ 14.38 Granted 2,943,582 $ 7.58 Vested and converted to shares (1,174,990) $ 15.33 Forfeited or canceled (1,670,799) $ 14.51 Balance as of April 30, 2022 10,282,007 $ 11.94
Schedule of Share-Based Compensation Expense	The Company's stock-based compensation expense for the periods presented was as follows: Three months ended April 30, (in thousands) 2022 2021 Cost of revenue $ 1,382 $ 1,445 Sales and marketing 6,376 5,501 Research and development 4,520 3,988 General and administrative 5,808 3,664 Total stock-based compensation expense $ 18,086 $ 14,598

Equity (Tables)

Equity (Tables)	3 Months Ended
	Apr. 30, 2022
Equity [Abstract]
Schedule of Stockholders Equity	The following table summarizes the changes in stockholders' equity during the three months ended April 30, 2022: Accumulated Additional Other Total Common Stock Paid-In Comprehensive Accumulated Treasury Stockholders’ (in thousands) Shares Amount Capital (Loss) Deficit Stock Equity Balance, January 31, 2022 131,157 $ 137 $ 834,429 $ (187) $ (610,604) $ (11,905) $ 211,870 Exercise of stock options 123 — 302 — — — 302 Vested restricted stock units converted to common shares 1,165 1 (1) — — — — Issuance of common stock under employee stock purchase plan 457 1 2,353 — — — 2,354 Stock-based compensation — — 18,201 — — — 18,201 Repurchase of common stock (4,838) — — — — (30,554) (30,554) Other comprehensive loss — — — (3,414) — — (3,414) Net loss — — — — (25,839) — (25,839) Balance, April 30, 2022 128,064 $ 139 $ 855,284 $ (3,601) $ (636,443) $ (42,459) $ 172,920 The following table summarizes the changes in stockholders' equity during the three months ended April 30, 2021: Accumulated Additional Other Total Common Stock Paid-In Comprehensive Accumulated Treasury Stockholders’ (in thousands) Shares Amount Capital Income Deficit Stock Equity Balance, January 31, 2021 123,989 $ 130 $ 733,933 $ 2,422 $ (517,345) $ (11,905) $ 207,235 Exercise of stock options 1,069 1 12,110 — — — 12,111 Vested restricted stock units converted to common shares 871 1 (1) — — — — Issuance of restricted stock 4 — — — — — — Issuance of common stock under employee stock purchase plan 282 — 3,817 — — — 3,817 Stock-based compensation — — 15,288 — — — 15,288 Other comprehensive income — — — 355 — — 355 Net loss — — — — (17,631) — (17,631) Balance, April 30, 2021 126,215 $ 132 $ 765,147 $ 2,777 $ (534,976) $ (11,905) $ 221,175

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2022
Leases [Abstract]
Lease, Cost	The Company recognized $6.6 million of lease expense for each the three months ended April 30, 2022 and 2021, which consisted of the following: Three months ended April 30, (in thousands) 2022 2021 Operating lease expense $ 4,280 $ 4,259 Short-term lease expense 206 188 Variable lease expense 2,145 2,165 Total lease expense $ 6,631 $ 6,612

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Contractual Obligation Payments	As of April 30, 2022, the Company's contractual obligations are as follows (in thousands): Fiscal year ending January 31: Operating Leases Other 2023 (remainder of fiscal year) $ 14,248 $ 27,556 2024 18,788 17,161 2025 18,324 9,186 2026 19,177 1,834 2027 19,273 1,538 2028 and thereafter 75,160 394 Total $ 164,970 $ 57,669

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders: Three months ended April 30, (in thousands, except share and per share data) 2022 2021 Numerator: Net loss attributable to common stockholders $ (25,839) $ (17,631) Denominator: Weighted-average common shares outstanding 131,144,055 125,372,839 Net loss per share attributable to common stockholders, basic and diluted $ (0.20) $ (0.14)
Schedule of Antidilutive Securities	Anti-dilutive common equivalent shares were as follows: As of April 30, 2022 2021 Options to purchase common stock 5,562,682 7,802,579 Restricted stock and restricted stock units 10,282,007 8,378,889 Shares estimated to be purchased under ESPP 340,938 213,434 Performance-based restricted stock units 2,000,000 — Total anti-dilutive common equivalent shares 18,185,627 16,394,902

Organization and Description _2

Organization and Description of Business (Details)	Apr. 30, 2022Provider
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of service and application providers	200

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - 3 months ended Apr. 30, 2022	segment	operatingSegment
Accounting Policies [Abstract]
Number of operating segments	1	1

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Revenue from External Customer [Line Items]
Unearned revenue, current	$ 196,379		$ 223,427
Unearned revenue, noncurrent	300
Unearned revenue, revenue recognized	86,200
Customer deposits	$ 1,500		$ 200
Sales Revenue, Net | Product Concentration Risk | Professional Services
Revenue from External Customer [Line Items]
Concentration risk, percentage	9.00%	8.00%
Sales Revenue, Net | Geographic Concentration Risk | UNITED STATES
Revenue from External Customer [Line Items]
Concentration risk, percentage	80.00%	79.00%
Sales Revenue, Net | Geographic Concentration Risk | UNITED KINGDOM
Revenue from External Customer [Line Items]
Concentration risk, percentage	18.00%	18.00%

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 98,802	$ 91,992
North America
Disaggregation of Revenue [Line Items]
Revenue	78,709	73,060
International
Disaggregation of Revenue [Line Items]
Revenue	$ 20,093	$ 18,932

Revenue - Revenue Performance O

Revenue - Revenue Performance Obligations (Details) - USD ($) $ in Millions	Apr. 30, 2022	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 360.6	$ 404.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	360.6	$ 404.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-05-01
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	341.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 341.1
Revenue, remaining performance obligation, expected timing of satisfaction, period	24 months

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Apr. 30, 2022	Jan. 31, 2022
Recurring | Fair Value, Inputs, Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, fair value disclosure	$ 113.4	$ 138.5

Goodwill (Details)

Goodwill (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2022USD ($)segment	Apr. 30, 2022USD ($)operatingSegment	Apr. 30, 2022USD ($)reportingUnit	Jan. 31, 2022USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill | $	$ 4,401	$ 4,401	$ 4,401	$ 4,572
Number of operating segments	1	1
Number of reporting units | reportingUnit			1

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 111,674		$ 110,893
Less: accumulated depreciation	(40,119)		(36,289)
Total property and equipment, net	71,555		74,604
Depreciation expense	$ 4,400	$ 3,600
Geographic Concentration Risk | UNITED STATES | Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Concentration risk, percentage	90.00%
Computer software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 19,885		18,814
Office equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	19,507		18,854
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	7,965		8,163
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	62,042		62,784
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,569		936
Software in progress
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 706		$ 1,342

Accounts Payable, Accrued Exp_3

Accounts Payable, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2022	Jan. 31, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 11,446	$ 9,218
Accrued employee compensation	16,593	17,589
Accrued Knowledge Network application provider fees	2,909	2,885
Accrued professional services and associated costs	2,341	2,663
Accrued employee stock purchase plan withholdings liability	650	2,397
Other current liabilities	20,510	13,680
Total accounts payable, accrued expenses and other current liabilities	54,449	48,432
Accounts Payable and Accrued Liabilities
Property, Plant and Equipment [Line Items]
Capital expenditures	$ 1,100	$ 900

Stock-Based Compensation - Plan

Stock-Based Compensation - Plans (Details) - shares	1 Months Ended	3 Months Ended
	Dec. 31, 2016	Apr. 30, 2022	Feb. 01, 2022	Mar. 10, 2016
2008 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)				25,912,531
2008 Equity Incentive Plan | Options to purchase common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award expiration period (in years)		10 years
Award vesting period (in years)		4 years
2016 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	10,000,000
Percentage of outstanding shares	4.00%
Number of shares authorized, annual increase (in shares)			5,246,279
Number of shares available for futures issuance (in shares)		6,334,782

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Outstanding Stock Options
Balance, beginning of period (in shares)	6,620,701
Granted (in shares)	0
Exercised (in shares)	(122,519)
Forfeited or canceled (in shares)	(935,500)
Balance, end of period (in shares)	5,562,682		6,620,701
Vested and expected to vest (in shares)	5,562,682
Exercisable at end of period (in shares)	5,562,682
Weighted-Average Exercise Price
Balance, beginning of period (in dollars per share)	$ 7.28
Granted (in dollars per share)	0
Exercised (in dollars per share)	2.48
Forfeited or canceled (in dollars per share)	12.47
Balance, end of period (in dollars per share)	6.52		$ 7.28
Vested and expected to vest (in dollars per share)	6.52
Exercisable at end of period (in dollars per share)	$ 6.52
Balance, weighted-average remaining contractual life (in years)	3 years 9 months 10 days		4 years 3 months 25 days
Vested and expected to vest, weighted-average remaining contractual life (in years)	3 years 9 months 10 days
Exercisable at end of period, weighted-average remaining contractual life (in years)	3 years 9 months 10 days
Balance, aggregate intrinsic value	$ 2,338		$ 11,723
Vested and expected to vest, aggregate intrinsic value	2,338
Exercisable at end of period, aggregate intrinsic value	2,338
Options exercised, intrinsic value	$ 500	$ 6,300

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock (Details) - Restricted stock and restricted stock units - $ / shares	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Outstanding
Balance, beginning of period (in shares)	10,184,214
Granted (in shares)	2,943,582
Vested and converted to shares (in shares)	(1,174,990)
Forfeited or canceled (in shares)	(1,670,799)
Balance, end of period (in shares)	10,282,007
Weighted-Average Grant Date Fair Value
Beginning of period (in dollars per share)	$ 14.38
Granted (in dollars per share)	7.58	$ 15.42
Vested and converted to shares (in dollars per share)	15.33
Forfeited or canceled (in dollars per share)	14.51
Balance, end of period (in dollars per share)	$ 11.94

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Mar. 15, 2022	Jan. 31, 2022	Feb. 01, 2022	Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock under employee stock purchase plan	$ 2,354	$ 3,817		$ 6,485
Expected volatility rate		59.24%
Stock-based compensation expense	$ 18,086	$ 14,598
Shares Committed under 2017 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized, annual increase (in shares)					1,311,569	2,500,000
Number of shares authorized, annual increase, percentage of outstanding shares at the end of prior fiscal year						1.00%
Number of shares authorized (in shares)	4,397,670
Issuance of common stock under employee stock purchase plan (in shares)	340,938		457,595
Shares purchased under plan (in dollars per share)			$ 5.14
Issuance of common stock under employee stock purchase plan			$ 2,400
Employee withholdings for future purchases under the ESPP	$ 700
Expected life (in years)	6 months
Expected volatility rate	48.87%
Risk free interest rate	0.86%	0.06%
Stock-based compensation expense	$ 400	$ 600
Unrecognized compensation cost	$ 400
Unrecognized compensation cost, period for recognition (in years)	4 months 17 days
Maximum payroll deduction (as a percent of eligible compensation)	15.00%
Purchase price of common stock (as a percent)	85.00%

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance-based Restricted Stock Units (Details)	3 Months Ended
	Apr. 30, 2022shares
Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	2,000,000

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 18,086	$ 14,598
Unrecognized compensation cost, stock options	122,900
Stock-based compensation related to internal-use software development	100	700
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,382	1,445
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	6,376	5,501
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	4,520	3,988
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 5,808	$ 3,664
Options to purchase common stock
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Unrecognized compensation cost, period for recognition (in years)	2 years 8 months 15 days

Equity - Changes in stockholder

Equity - Changes in stockholders' equity (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period	$ 211,870	$ 207,235	$ 207,235
Exercise of stock options (in shares)	122,519
Exercise of stock options	$ 302	12,111	19,197
Vested restricted stock units converted to common shares	0	0	0
Issuance of restricted stock		0	0
Issuance of common stock under employee stock purchase plan	2,354	3,817	6,485
Stock-based compensation	18,201	15,288	74,821
Repurchase of common stock	(30,554)
Other comprehensive income (loss)	(3,414)	355	(2,609)
Net loss	(25,839)	(17,631)	(93,259)
End of period	$ 172,920	$ 221,175	$ 211,870
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period (in shares)	131,157,000	123,989,000	123,989,000
Beginning of period	$ 137	$ 130	$ 130
Exercise of stock options (in shares)	123,000	1,069,000	2,220,000
Exercise of stock options	$ 0	$ 1	$ 2
Vested restricted stock units converted to common shares (in shares)	1,165,000	871,000	4,402,000
Vested restricted stock units converted to common shares	$ 1	$ 1	$ 4
Issuance of restricted stock (in shares)		4,000	15,000
Issuance of common stock under employee stock purchase plan (in shares)	457,000	282,000	531,000
Issuance of common stock under employee stock purchase plan	$ 1		$ 1
Repurchase of common stock (in shares)	(4,838,000)
End of period (in shares)	128,064,000	126,215,000	131,157,000
End of period	$ 139	$ 132	$ 137
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period	834,429	733,933	733,933
Exercise of stock options	302	12,110	19,195
Vested restricted stock units converted to common shares	(1)	(1)	(4)
Issuance of common stock under employee stock purchase plan	2,353	3,817	6,484
Stock-based compensation	18,201	15,288	74,821
End of period	855,284	765,147	834,429
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period	(187)	2,422	2,422
Other comprehensive income (loss)	(3,414)	355	(2,609)
End of period	(3,601)	2,777	(187)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period	(610,604)	(517,345)	(517,345)
Net loss	(25,839)	(17,631)	(93,259)
End of period	(636,443)	(534,976)	(610,604)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning of period	(11,905)	(11,905)	(11,905)
Repurchase of common stock	(30,554)
End of period	$ (42,459)	$ (11,905)	$ (11,905)

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Jun. 09, 2022USD ($)	Jun. 09, 2022USD ($)	Apr. 30, 2022USD ($)vote$ / sharesshares	Mar. 31, 2022USD ($)	Jan. 31, 2022USD ($)vote$ / sharesshares	Apr. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock shares authorized (in shares) | shares			50,000,000		50,000,000	50,000,000
Preferred stock par value (in dollars per share) | $ / shares			$ 0.001		$ 0.001	$ 0.001
Preferred stock shares issued (in shares) | shares			0		0
Preferred stock shares outstanding (in shares) | shares			0		0
Common stock shares authorized (in shares) | shares			500,000,000		500,000,000
Common stock par value (in dollars per share) | $ / shares			$ 0.001		$ 0.001
Common stock number of votes | vote			1		1
Treasury stock (in shares) | shares			11,343,518		6,505,334
Treasury stock, at cost | $			$ (42,459)		$ (11,905)
Share Repurchase Program 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount | $				$ 100,000
Shares repurchased during period (in shares) | shares			4,838,184
Shares repurchased, average price per share (in dollars per share) | $ / shares			$ 6.32
Value of shares repurchased during period | $			$ 30,600
Stock repurchase program, remaining authorized repurchase amount | $			$ 69,400
Share Repurchase Program 2022 | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares repurchased during period | $	$ 24,000	$ 55,000
Stock repurchase program, remaining authorized repurchase amount | $	$ 45,000	$ 45,000

Debt (Details)

Debt (Details) $ in Millions	Mar. 11, 2020USD ($)Rate	Apr. 30, 2022USD ($)quarter
Line of Credit Facility [Line Items]
Number of fiscal quarters | quarter		4
Secured Debt | Revolving Credit Line
Line of Credit Facility [Line Items]
Borrowing capacity	$ 50	$ 50
Debt instrument term (in years)	3 years
Incremental borrowing available under certain conditions	$ 50
Capital stock of foreign subsidiary, percent	66.00%
Covenant terms, minimum adjusted quick ratio | Rate	0.015%
Line of credit facility, available borrowing capacity		35.7
Secured Debt | London Interbank Offered Rate (LIBOR) | Revolving Credit Line | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	2.50%
Secured Debt | London Interbank Offered Rate (LIBOR) | Revolving Credit Line | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	3.00%
Secured Debt | Base Rate | Revolving Credit Line | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.50%
Secured Debt | Base Rate | Revolving Credit Line | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.00%
Line of Credit | Letter of Credit
Line of Credit Facility [Line Items]
Borrowing capacity	$ 30
Debt instrument, collateral amount		$ 14.3
Line of Credit | Bridge Loan
Line of Credit Facility [Line Items]
Borrowing capacity	$ 10

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Income Tax Disclosure [Abstract]
(Provision for) benefit from income taxes	$ (348)	$ (187)

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Jan. 31, 2022
Leases [Abstract]
Operating lease liabilities, current	$ 18,236	$ 18,845
Operating lease liabilities, non-current	109,959	113,776
Operating lease right-of-use assets	$ 93,554	$ 97,124
Operating lease, weighted average remaining lease term (in years)	8 years 6 months
Operating lease, weighted average discount rate, percentage	5.90%
Operating lease, payments	$ 5,100

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Leases [Abstract]
Operating lease expense	$ 4,280	$ 4,259
Short-term lease expense	206	188
Variable lease expense	2,145	2,165
Total lease expense	$ 6,631	$ 6,612

Commitments and Contingencies -

Commitments and Contingencies - Contractual Obligations (Details) $ in Thousands	Apr. 30, 2022USD ($)
Operating Leases
2023 (remainder of fiscal year)	$ 14,248
2024	18,788
2025	18,324
2026	19,177
2027	19,273
2028 and thereafter	75,160
Total	164,970
Other
2023 (remainder of fiscal year)	27,556
2024	17,161
2025	9,186
2026	1,834
2027	1,538
2028 and thereafter	394
Total	$ 57,669

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Numerator:
Net loss attributable to common stockholders	$ (25,839)	$ (17,631)	$ (93,259)
Denominator:
Weighted-average common shares outstanding, basic (in shares)	131,144,055	125,372,839
Weighted-average common shares outstanding, diluted (in shares)	131,144,055	125,372,839
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.20)	$ (0.14)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.20)	$ (0.14)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive common equivalent shares (Details) - shares	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common equivalent shares (in shares)	18,185,627	16,394,902
Restricted stock and restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common equivalent shares (in shares)	10,282,007	8,378,889
Shares estimated to be purchased under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common equivalent shares (in shares)	340,938	213,434
Performance-based restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common equivalent shares (in shares)	2,000,000	0
Common Stock | Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common equivalent shares (in shares)	5,562,682	7,802,579